Kiadis Pharma N.V. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
102.00
126.00
140.00
150.00
177.00
1,047
Gross Income
102.00
126.00
140.00
150.00
177.00
1,047
SG&A Expense
4,810.00
6,042.00
15,867.00
11,258.00
15,943.00
24,154
EBIT
4,912.00
6,168.00
16,007.00
11,408.00
16,120.00
25,201
Unusual Expense
98.00
928.00
1,895.00
2,213.00
650.00
589
Non Operating Income/Expense
1,240.00
330.00
1,001.00
386.00
722.00
301
Interest Expense
920.00
1,073.00
1,394.00
1,571.00
2,285.00
4,302
Pretax Income
6,885.00
7,811.00
16,457.00
14,793.00
17,033.00
29,791
Income Tax
-
2.00
1.00
1.00
5.00
10
Consolidated Net Income
6,885.00
7,813.00
16,458.00
14,794.00
17,038.00
29,801
Net Income
6,885.00
7,813.00
16,458.00
14,794.00
17,038.00
29,801
Net Income After Extraordinaries
6,885.00
7,813.00
16,458.00
14,794.00
17,038.00
29,801
Net Income Available to Common
6,885.00
7,813.00
16,458.00
14,794.00
17,038.00
29,801
EPS (Basic)
-
-
1.36
1.08
1.14
1.46
Basic Shares Outstanding
13,700.20
13,700.20
12,057.30
13,754.70
14,950.70
20,450.40
EPS (Diluted)
0.50
0.57
1.36
1.08
1.14
1.46
Diluted Shares Outstanding
13,700.20
13,700.20
12,057.30
13,754.70
14,950.70
20,450.40
EBITDA
4,810.00
6,042.00
15,867.00
11,258.00
15,943.00
24,154
Non-Operating Interest Income
89.00
28.00
50.00
13.00
-
-
About Kiadis Pharma
View Profile
